Methylin is a central nervous system stimulant. It’s a common treatment for attention-deficit disorder (ADD) and narcolepsy. Methylin has an above average rate of addiction and should only be taken as prescribed. Addiction rates are not as high with Methylin as they are with most other central nervous system stimulants.
Methylin achieves its effects by increasing the expression of the neurotransmitters norepinephrine and dopamine. Underactivity of these neurotransmitters are linked to worse cases of hyperactivity disorders like attention deficit disorder (ADD).
Methylin use can result in side effects that affect digestion, the heart, the eyes and mental health. Common side effects include rapid heart rate, anxiety, dry mouth, nausea, insomnia, abdominal pain, irritability, dizziness, heart palpitations, fluctuations in blood pressure, rapid heart rate and blurred vision. Chest pain has also been reported on rare occasions. Individuals may also experience increased sweating, teeth-grinding (bruxism) and restlessness.
Most patients experience some level of post-acute withdrawal symptoms upon cessation of treatment with Methylin. The intensity of withdrawals can be minimized by gradually reducing the dose over a period. A dose-tapering period of one week is advised. Patients who have been taking it longer may require an extended dose reduction phase.
Withdrawal symptoms of Methylin discontinuation may include extreme fatigue, insomnia, tremors, depression, anxiety, sexual dysfunction, headache and dizziness. Constipation and dry mouth may also occur. More severe side effects of Methylin withdrawal can include irregular heartbeat, heart attack, seizures, aggression, dangerously high body temperatures, extreme paranoia, uncontrolled body movement, verbal tics and difficulty urinating. Patients occasionally report the vivid dreams and nightmares.
Methylin withdrawals can last anywhere from a few days to several weeks. For most individuals, withdrawals begin within 24 hours of the time of the last dose. Withdrawal symptoms typically peak in intensity after two days. Although withdrawals from Methylin can be physically and psychologically uncomfortable, they are not in themselves life-threatening. However, patients should be monitored for an increased risk of suicidal thoughts. The onset of suicidal thoughts is more common among young adults and adolescents.
Detoxing from Methylin does not typically call for the use of other medications to ease withdrawals. With Methylin addiction, it’s most effective to gradually taper doses until the patient is ready to halt stimulant use entirely. Patients experiencing depression as part of Methylin withdrawals may benefit from taking a selective serotonin reuptake inhibitor (SSRI) like Prozac. SSRIs have been proven to be effective at reducing symptoms of depression and minimizing withdrawals from some substances. Naltrexone is another antidepressant that is commonly used in the management of withdrawals from opioids and alcohol. Naltrexone has also been shown to be a potential for the treatment of stimulant addiction.
In case of severe addiction, a coordinated intervention involving close friends and family may be necessary. The intervention should take place in a safe space where all members feel comfortable expressing themselves. Family and friends should focus on sharing how the individual’s drug use has negatively affected them. Comments should remain non-accusatory and keep in mind that the loved one can choose to leave at any time.
Methylin withdrawals are often best managed under medical supervision. In patients severely addicted to Methylin, medical detox may be an appropriate option. In medical detox, individuals are continuously monitored, and withdrawal symptoms can be mitigated with a steady supply of I.V. fluids.
Methylin is occasionally administered to patients withdrawing from stronger stimulants to gradually wean them off stimulant use. Discontinuation from methamphetamine or cocaine, for example, may warrant the use of small doses of Methylin to ease withdrawals.
Several options exist for recovery from addiction to Methylin and other central nervous system stimulants. Following a successful intervention, the patient will either enter medical detox or head directly to an inpatient recovery program. People who have been taking central nervous stimulants like Methylin for a while will likely be asked to undergo medical detox before beginning a recovery program. This is to ensure the safety of the patient and allows for a smooth transition into the program.
Several types of inpatient recovery programs exist. Some programs are strictly for adolescents, while others only allow adults. A small percentage of inpatient rehab facilities are specific to gender. Wilderness recovery programs are increasingly more popular for adolescents. In wilderness-based recovery programs, individuals venture into the wilderness with a small group of fellow recovering patients. Counselors and survival instructors accompany them. The goal of wilderness-based programs is to teach self-reliance while educating participants on the nature of drug addiction.
Inpatient programs are generally followed up with several months of outpatient therapy. Outpatient treatment programs meet roughly three times a week for a couple of hours per session. Therapy is conducted in a group setting. Attendance of Narcotics Anonymous or Alcoholics Anonymous meetings may also be required.
If you or a loved one is struggling with substance use disorder, contact us online or through our 24/7 confidential helpline at 888-328-0742 to learn more about the road to recovery. We can help you overcome your addiction today.
Methylin Addiction Treatment And Rehab
The Recovery Village aims to improve the quality of life for people struggling with substance use or mental health disorder with fact-based content about the nature of behavioral health conditions, treatment options and their related outcomes. We publish material that is researched, cited, edited and reviewed by licensed medical professionals. The information we provide is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified healthcare providers.